查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1907930

心肌肌钙蛋白市场：按肌钙蛋白类型、产品类型、检测形式、样本类型、检测灵敏度、技术平台、临床应用、反应时间、年龄层、最终用户、通路和地区划分

Cardiac Troponin Market, By Troponin Type, By Product Type, By Test Format, By Sample Type, By Assay Sensitivity, By Technology Platform, By Clinical Application, By Turnaround Time, By Age Group, By End User, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，心臟肌钙蛋白市场规模为 44.1 亿美元，到 2032 年将达到 87.6 亿美元，2025 年至 2032 年的复合年增长率为 10.3%。

分析范围 分析详情
基准年 2024 市场规模（2025 年） 44.1亿美元
效能数据 2020-2024 预测期 2025-2032
预测期（2025-2032 年）复合年增长率 10.30% 预计金额（2032 年） 87.6亿美元

全球心肌肌钙蛋白市场规模预计在2025年为44.1亿美元，预计2032年将达到87.6亿美元，2025年至2032年的复合年增长率为10.3%。全球心肌肌钙蛋白市场是心血管诊断产业的关键细分市场，专注于生物标记检测，这些检测彻底改变了急性心肌梗塞的诊断和心臟护理管理。

心肌肌钙蛋白，特别是肌钙蛋白 I (cTnI) 和肌钙蛋白 T (cTnT)，是高度敏感和特异的蛋白质生物标记物，在心肌细胞受损时释放到血液中，是诊断心肌梗塞和其他急性冠状动脉症候群的黄金标准。

该市场涵盖多种调查方法，例如高灵敏度肌钙蛋白检测法、就地检验设备和检查室免疫检测系统，这些方法能够快速且准确地检测心臟事件。随着全球心血管疾病的增加、人口老化以及人们对早期心臟干预意识提升，心臟肌钙蛋白检测市场正在经历显着增长和技术进步。

全球医疗机构依赖这些诊断工具来做出关键的临床决策、降低病患死亡率并优化治疗通讯协定。该市场服务于各种医疗机构，从急诊​​和加护病房到门诊诊所和诊断检查室，支援已开发和新兴医疗市场中的急诊和常规心臟监测应用。

市场动态

全球心臟肌钙蛋白市场的主要驱动力是全球心血管疾病的日益流行，心血管疾病仍然是全球主要的死亡原因，每年影响数百万人，并对准确的诊断解决方案产生了巨大的需求。

人口老化加剧也是市场成长的重要推手。老年人发生心臟事件的风险更高，因此需要频繁监测和早期检测。高灵敏度肌钙蛋白检测技术的进步显着提高了诊断准确性，能够检测到极轻微的心臟损伤，有助于采取早期疗育策略，改善患者预后。

急诊和重症监护室对就地检验设备的日益普及，透过更快地获得检测结果，加快临床决策过程，从而推动了市场扩张。然而，先进肌钙蛋白检测设备和试剂的高成本等阻碍因素，可能会阻碍资源匮乏的医疗机构和发展中地区的应用。此外，诊断设备核准的严格监管要求也可能导致产品上市延迟和研发成本增加，从而阻碍市场成长。

某些患者群体中出现的假阳性结果以及各种病理因素的干扰，都构成了临床挑战，可能影响检测的可靠性和医生的信心。然而，新兴市场，特别是亚太和拉丁美洲地区，透过不断完善的医疗基础设施，蕴藏着巨大的成长机会。这些地区医疗投资的增加以及人们对心臟健康的日益重视，创造了巨大的成长潜力。开发具有更高特异性和灵敏度的新一代肌钙蛋白检测方法，为市场差异化和高端定位提供了机会。

本报告的主要特点

  • 本报告对全球心臟肌钙蛋白市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
  • 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
  • 全球心肌肌钙蛋白市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告提供的见解将使负责人和公司经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
  • 《全球心臟肌钙蛋白市场》报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球心臟肌钙蛋白市场的各种策略矩阵，更轻鬆地做出决策。

目录

第一章 分析目标和先决条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特五力分析
  • 企业合併情景
  • 产业趋势

4. 全球心肌肌钙蛋白市场（依肌钙蛋白类型划分）（2020-2032 年）

  • 心肌肌钙蛋白I（cTnI）
  • 心肌肌钙蛋白T（cTnT）

5. 全球心肌肌钙蛋白市场（依产品类型划分）（2020-2032 年）

  • 试剂和试剂盒
  • 校准器、控制器
  • 耗材和配件

6. 全球心肌肌钙蛋白市场（依检测类型划分）（2020-2032 年）

  • 检查室肌钙蛋白检测
  • 照护现场（POC​​）肌钙蛋白检测

7. 全球心肌肌钙蛋白市场（依样本类型划分）（2020-2032 年）

  • 全血
  • 血清
  • 电浆

8. 全球心肌肌钙蛋白市场（依检测灵敏度划分）（2020-2032 年）

  • 常规/标准灵敏度肌钙蛋白检测法
  • 高敏感性肌钙蛋白检测法（hs-cTn）

9. 全球心肌肌钙蛋白市场依技术平台划分（2020-2032 年）

  • 化学冷光免疫检测（CLIA）
  • 酵素免疫分析法（ELISA）
  • 萤光免疫分析
  • 层析法
  • 电化学免疫检测
  • 其他免疫检测

10. 全球心臟肌钙蛋白市场依临床应用划分（2020-2032 年）

  • 急性心肌梗塞（AMI）的诊断
  • 急性冠状动脉症候群（ACS）风险分层
  • 心肌损伤监测（非急性心肌梗塞原因）
  • 预后和结果评估

11. 全球心肌肌钙蛋白市场（依反应时间划分）（2020-2032 年）

  • 快速检测（不到30分钟）
  • 标准测试（超过30分钟）

第十二章 全球心臟肌钙蛋白市场（依年龄层划分）（2020-2032 年）

  • 成人
  • 老年人

13. 全球心肌肌钙蛋白市场（依最终用户划分）（2020-2032 年）

  • 医院
  • 诊断检查室
  • 急诊中心
  • 心臟诊所
  • 门诊治疗中心
  • 研究和学术机构

14. 全球心肌肌钙蛋白市场依通路划分（2020-2032 年）

  • 在线的
  • 离线

15. 全球心臟肌钙蛋白市场（按地区划分）（2020-2032 年）

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 其他亚太地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十六章 竞争格局

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • bioMerieux
  • Ortho Clinical Diagnostics
  • Danaher Corporation
  • QuidelOrtho
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • DiaSorin
  • Fujirebio
  • Randox Laboratories
  • Tosoh Bioscience
  • Snibe Diagnostic

第十七章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map (COM)

第十八章 参考文献与分析方法

  • 参考
  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI9082

Cardiac Troponin Market is estimated to be valued at USD 4.41 Bn in 2025 and is expected to reach USD 8.76 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.41 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.30% 2032 Value Projection: USD 8.76 Bn

The Global Cardiac Troponin Market is estimated to be valued at USD 4.41 Bn in 2025 and is expected to reach USD 8.76 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2025 to 2032. The global cardiac troponin market represents a critical segment within the cardiovascular diagnostic industry, focusing on biomarker testing that has revolutionized acute myocardial infarction diagnosis and cardiac care management.

Cardiac troponins, specifically troponin I (cTnI) and troponin T (cTnT), are highly sensitive and specific protein biomarkers released into the bloodstream when cardiac muscle cells are damaged, making them the gold standard for diagnosing heart attacks and other acute coronary syndromes.

The market encompasses various testing methodologies including high-sensitivity troponin assays, point-of-care testing devices, and laboratory-based immunoassay systems that enable rapid and accurate detection of cardiac events. With the increasing global burden of cardiovascular diseases, aging populations, and rising awareness about early cardiac intervention, the cardiac troponin testing market has experienced substantial growth and technological advancement.

Healthcare providers worldwide rely on these diagnostic tools to make critical clinical decisions, reduce patient mortality rates, and optimize treatment protocols. The market serves diverse healthcare settings from emergency departments and intensive care units to outpatient clinics and diagnostic laboratories, supporting both acute care scenarios and routine cardiac monitoring applications across developed and emerging healthcare markets globally.

Market Dynamics

The global cardiac troponin market is primarily driven by the escalating prevalence of cardiovascular diseases worldwide, which remains the leading cause of mortality globally, affecting millions annually and creating substantial demand for accurate diagnostic solutions.

The aging population demographic significantly contributes to market growth as elderly individuals face higher risks of cardiac events, necessitating frequent monitoring and early detection capabilities. Technological advancements in high-sensitivity troponin assays have revolutionized diagnostic precision, enabling detection of even minute levels of cardiac damage and facilitating earlier intervention strategies that improve patient outcomes.

The growing adoption of point-of-care testing devices in emergency departments and critical care settings drives market expansion by providing rapid results that accelerate clinical decision-making processes. However, the market faces certain restraints including high costs associated with advanced troponin testing equipment and reagents, which may limit adoption in resource-constrained healthcare facilities and developing regions. Stringent regulatory requirements for diagnostic device approvals can delay product launches and increase development costs, potentially hindering market growth.

False positive results in certain patient populations and interference from various medical conditions pose clinical challenges that may affect test reliability and physician confidence. Nevertheless, significant opportunities exist through expanding healthcare infrastructure in emerging markets, particularly in Asia Pacific and Latin America, where increasing healthcare investments and rising awareness about cardiac health create substantial growth potential. The development of next-generation troponin assays with enhanced specificity and sensitivity presents opportunities for market differentiation and premium positioning.

Key Features of the Study

  • This report provides in-depth analysis of the global cardiac troponin market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiac troponin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics, Danaher Corporation, QuidelOrtho, Thermo Fisher Scientific, Sysmex Corporation, DiaSorin, Fujirebio, Randox Laboratories, Tosoh Bioscience, and Snibe Diagnostic
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cardiac troponin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac troponin market

Market Segmentation

  • Troponin Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Cardiac Troponin I (cTnI)
    • Cardiac Troponin T (cTnT)
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Reagents and Kits
    • Calibrators and Controls
    • Consumables and Accessories
  • Test Format Insights (Revenue, USD Bn, 2020 - 2032)
    • Laboratory-Based Troponin Tests
    • Point-of-Care (POC) Troponin Tests
  • Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Whole Blood
    • Serum
    • Plasma
  • Assay Sensitivity Insights (Revenue, USD Bn, 2020 - 2032)
    • Conventional/Standard Sensitivity Troponin Assays
    • High-Sensitivity Troponin Assays (hs-cTn)
  • Technology Platform Insights (Revenue, USD Bn, 2020 - 2032)
    • Chemiluminescence Immunoassays (CLIA)
    • Enzyme-Linked Immunosorbent Assays (ELISA)
    • Fluorescence Immunoassays
    • Immunochromatographic Assays
    • Electrochemical Immunoassays
    • Other immunoassay methods
  • Clinical Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Acute Myocardial Infarction (AMI) Diagnosis
    • Acute Coronary Syndrome (ACS) Risk Stratification
    • Myocardial Injury Monitoring (Non-AMI Causes)
    • Prognostic and Outcome Assessment
  • Turnaround Time Insights (Revenue, USD Bn, 2020 - 2032)
    • Rapid Tests (<30 minutes)
    • Standard Tests (>=30 minutes)
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult Population
    • Geriatric Population
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Laboratories
    • Emergency Care Centers
    • Cardiac Specialty Clinics
    • Ambulatory Care Centers
    • Research and Academic Institutes
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Beckman Coulter
    • bioMerieux
    • Ortho Clinical Diagnostics
    • Danaher Corporation
    • QuidelOrtho
    • Thermo Fisher Scientific
    • Sysmex Corporation
    • DiaSorin
    • Fujirebio
    • Randox Laboratories
    • Tosoh Bioscience
    • Snibe Diagnostic

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cardiac Troponin Market, By Troponin Type
    • Global Cardiac Troponin Market, By Product Type
    • Global Cardiac Troponin Market, By Test Format
    • Global Cardiac Troponin Market, By Sample Type
    • Global Cardiac Troponin Market, By Assay Sensitivity
    • Global Cardiac Troponin Market, By Technology Platform
    • Global Cardiac Troponin Market, By Clinical Application
    • Global Cardiac Troponin Market, By Turnaround Time
    • Global Cardiac Troponin Market, By Age Group
    • Global Cardiac Troponin Market, By End User
    • Global Cardiac Troponin Market, By Distribution Channel
    • Global Cardiac Troponin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Cardiac Troponin Market, By Troponin Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiac Troponin I (cTnI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Troponin T (cTnT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Cardiac Troponin Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Calibrators and Controls
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cardiac Troponin Market, By Test Format, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Laboratory-Based Troponin Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Point-of-Care (POC) Troponin Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cardiac Troponin Market, By Sample Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Whole Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Serum
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Plasma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cardiac Troponin Market, By Assay Sensitivity, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Conventional/Standard Sensitivity Troponin Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • High-Sensitivity Troponin Assays (hs-cTn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cardiac Troponin Market, By Technology Platform, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chemiluminescence Immunoassays (CLIA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Enzyme-Linked Immunosorbent Assays (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fluorescence Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunochromatographic Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electrochemical Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other immunoassay methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Cardiac Troponin Market, By Clinical Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Acute Myocardial Infarction (AMI) Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Acute Coronary Syndrome (ACS) Risk Stratification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Myocardial Injury Monitoring (Non-AMI Causes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prognostic and Outcome Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Cardiac Troponin Market, By Turnaround Time, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Rapid Tests (<30 minutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Standard Tests (>=30 minutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Cardiac Troponin Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult Population
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatric Population
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Cardiac Troponin Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emergency Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

14. Global Cardiac Troponin Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

15. Global Cardiac Troponin Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Troponin Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Test Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Assay Sensitivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Clinical Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Turnaround Time, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

16. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • bioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QuidelOrtho
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujirebio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Randox Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Tosoh Bioscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Snibe Diagnostic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

17. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

18. References and Research Methodology

  • References
  • Research Methodology
  • About us